A detailed history of Rowland & CO Investment Counsel transactions in Abbott Laboratories stock. As of the latest transaction made, Rowland & CO Investment Counsel holds 2,116 shares of ABT stock, worth $239,319. This represents 0.05% of its overall portfolio holdings.

Number of Shares
2,116
Previous 2,283 7.31%
Holding current value
$239,319
Previous $259,000 15.44%
% of portfolio
0.05%
Previous 0.06%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 29, 2024

SELL
$100.73 - $112.44 $16,821 - $18,777
-167 Reduced 7.31%
2,116 $219,000
Q3 2023

Oct 26, 2023

SELL
$95.53 - $114.62 $30,569 - $36,678
-320 Reduced 12.29%
2,283 $221,000
Q2 2023

Aug 04, 2023

BUY
$100.78 - $112.29 $1,108 - $1,235
11 Added 0.42%
2,603 $283,000
Q1 2023

Apr 25, 2023

SELL
$96.86 - $114.01 $3,196 - $3,762
-33 Reduced 1.26%
2,592 $262,000
Q4 2021

Feb 14, 2022

BUY
$115.53 - $141.46 $9,820 - $12,024
85 Added 3.35%
2,625 $369,000
Q3 2021

Nov 08, 2021

BUY
$116.66 - $129.06 $10,499 - $11,615
90 Added 3.67%
2,540 $300,000
Q2 2021

Aug 09, 2021

SELL
$105.79 - $124.53 $18,513 - $21,792
-175 Reduced 6.67%
2,450 $284,000
Q1 2021

May 11, 2021

SELL
$108.84 - $128.23 $8,163 - $9,617
-75 Reduced 2.78%
2,625 $314,000
Q4 2020

Feb 11, 2021

BUY
$105.0 - $114.42 $16,800 - $18,307
160 Added 6.3%
2,700 $295,000
Q1 2020

May 11, 2020

SELL
$62.82 - $91.86 $3,769 - $5,511
-60 Reduced 2.31%
2,540 $200,000
Q4 2019

Jan 28, 2020

BUY
$78.51 - $87.4 $13,739 - $15,295
175 Added 7.22%
2,600 $225,000
Q3 2019

Oct 02, 2019

BUY
$81.84 - $88.74 $16,368 - $17,748
200 Added 8.99%
2,425 $202,000
Q4 2018

Feb 12, 2019

BUY
$65.56 - $74.27 $52,448 - $59,416
800 Added 56.14%
2,225 $160,000
Q3 2018

Oct 22, 2018

BUY
$60.81 - $73.36 $86,654 - $104,538
1,425 New
1,425 $0
Q1 2018

Apr 17, 2018

SELL
$56.27 - $63.62 $100,160 - $113,243
-1,780 Closed
0 $0
Q4 2017

Jan 11, 2018

BUY
$53.68 - $57.47 $95,550 - $102,296
1,780
1,780 $0

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $198B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Rowland & CO Investment Counsel Portfolio

Follow Rowland & CO Investment Counsel and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rowland & CO Investment Counsel, based on Form 13F filings with the SEC.

News

Stay updated on Rowland & CO Investment Counsel with notifications on news.